Addressing Help-Seeking Barriers in Developing an Intensive Treatment for Veterans With Panic Disorder
The purpose of this study is to understand some of the reasons why recently deployed veterans decline psychosocial treatment options for panic disorder and to test a brief weekend treatment for panic attacks.
|Study Design:||Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Addressing Help-Seeking Barriers in Developing an Intensive Treatment for Veterans With Panic Disorder|
- Qualitative data regarding treatment seeking barriers [ Time Frame: 6 months ] [ Designated as safety issue: No ]
- Panic attack frequency and severity; treatment acceptability [ Time Frame: 6 months ] [ Designated as safety issue: No ]
|Study Start Date:||March 2008|
|Study Completion Date:||July 2009|
|Primary Completion Date:||March 2008 (Final data collection date for primary outcome measure)|
cognitive- behavioral treatment for panic disorder.
Other Name: CBT
The population of interest for this program includes men and women returning from deployment in Iraq or Afghanistan who are seen in the TRP at the MEDVAMC. The study consists of two parts: PART 1 involves a qualitative investigation of treatment-seeking barriers specific to persons who refuse standard treatments and PART 2 is a pilot intervention to treat panic symptoms in service members who have co-existing PTSD symptoms. PART 1 will include approximately 15 individuals who will be interviewed by a member of the study staff. Patients will be interviewed individually following a semi-structured questionnaire designed to help identify treatment-seeking barriers. PART 2 will include 8 individuals who will be enrolled in an open-trial of a two-day intensive cognitive-behavioral treatment for panic disorder, which will occur over the weekend. No participants will be assigned to a control condition. All activities related to this project including the interviews and intervention will be delivered in either the TRP at the MEDVAMC or at the Houston Center for Quality of Care and Utilization Studies (HCQCUS), a nearby facility.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00628979
|United States, Texas|
|Michael E. DeBakey VA Medical Center (152)|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Ellen Teng, PhD||Michael E. DeBakey VA Medical Center (152)|